Conv. Plasma
Nigella Sativa

All aspirin studies
Meta analysis
study COVID-19 treatment researchAspirinAspirin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Association between prior cardiometabolic therapy and in-hospital mortality in very old patients with type 2 diabetes mellitus hospitalized due to COVID-19. A nationwide observational study in Spain

Ramos-Rincón et al., Research Square, doi:10.21203/
Dec 2020  
  Source   PDF   All Studies   Meta AnalysisMeta
0 0.5 1 1.5 2+ Mortality -29% Improvement Relative Risk Aspirin for COVID-19  Ramos-Rincón et al.  Prophylaxis Is prophylaxis with aspirin beneficial for COVID-19? Retrospective 790 patients in Spain (March - May 2020) Higher mortality with aspirin (p=0.02) Ramos-Rincón et al., Research Square, Dec 2020 Favors aspirin Favors control
Aspirin for COVID-19
24th treatment shown to reduce risk in August 2021
*, now known with p = 0.000087 from 73 studies, recognized in 3 countries.
Lower risk for mortality and progression.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,200+ studies for 70+ treatments.
Retrospective 790 hospitalized type 2 diabetes patients ≥80 years old in Spain, showing higher mortality with existing aspirin use.
Study covers aspirin and metformin.
risk of death, 28.9% higher, RR 1.29, p = 0.02, treatment 132 of 264 (50.0%), control 253 of 526 (48.1%), adjusted per study, odds ratio converted to relative risk, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ramos-Rincón et al., 28 Dec 2020, retrospective, Spain, preprint, 25 authors, study period 1 March, 2020 - 29 May, 2020. Contact:
This PaperAspirinAll
{ 'institution': [{'name': 'Research Square'}], 'indexed': {'date-parts': [[2022, 4, 5]], 'date-time': '2022-04-05T14:34:08Z', 'timestamp': 1649169248491}, 'posted': {'date-parts': [[2020, 12, 28]]}, 'group-title': 'In Review', 'reference-count': 0, 'publisher': 'Research Square Platform LLC', 'license': [ { 'start': { 'date-parts': [[2020, 12, 28]], 'date-time': '2020-12-28T00:00:00Z', 'timestamp': 1609113600000}, 'content-version': 'unspecified', 'delay-in-days': 0, 'URL': ''}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'accepted': {'date-parts': [[2020, 12, 21]]}, 'abstract': '<jats:title>Abstract</jats:title>\n' ' <jats:p>Background\n' '\n' 'Advanced age and diabetes are both associated with poor prognosis in COVID-19. However, the ' 'effects of cardiometabolic drugs on the prognosis of diabetic patients with COVID-19, ' 'especially very old patients, are not well-known. This work aims to analyze the association ' 'between preadmission cardiometabolic therapy (antidiabetic, antiaggregant, antihypertensive, ' 'and lipid-lowering drugs) and in-hospital mortality among patients\u2009≥\u200980 years with ' 'type 2 diabetes mellitus hospitalized for COVID-19.\n' 'Methods\n' '\n' 'We conducted a nationwide, multicenter, retrospective, observational study in patients\u2009' '≥\u200980 years with type 2 diabetes mellitus and COVID-19 hospitalized in 160 Spanish ' 'hospitals between March 1 and May 29, 2020 who were included in the SEMI-COVID-19 Registry. ' 'The primary outcome measure was in-hospital mortality. A multivariate logistic regression ' 'analysis were performed to assess the association between preadmission cardiometabolic ' 'therapy and in-hospital mortality. The regression analysis values were expressed as adjusted ' 'odds ratios (AOR) with a 95% confidence interval (CI). In order to select the variables, the ' 'forward selection Wald statistic was used. Discrimination of the fitted logistic model was ' 'assessed via a receiver operating characteristic (ROC) curve. The Hosmer-Lemeshow test for ' 'logistic regression was used to determine the model’s goodness of fit.\n' 'Results\n' '\n' 'Of the 2,763 patients ≥80 years old hospitalized due to COVID-19, 790 (28.6%) had T2DM. Of ' 'these patients, 385 (48.7%) died during admission. On the multivariate analysis, the use of ' 'dipeptidyl peptidase-4 inhibitors (AOR 0.502, 95% CI 0.309–0.815, p\u2009=\u20090.005) and ' 'angiotensin receptor blockers (AOR 0.454, 95% CI 0.274–0.759, p\u2009=\u20090.003) were ' 'independent protectors against in-hospital mortality whereas the use of acetylsalicylic acid ' 'was associated with higher in-hospital mortality (AOR 1.761, 95% CI 1.092–2.842, p\u2009' '=\u20090.020). Other antidiabetic drugs, angiotensin-converting enzyme inhibitors and statins ' 'showed neutral association with in-hospital mortality. The model showed an area under the ' 'curve of 0.788.\n' 'Conclusions\n' '\n' 'We found important differences between cardiometabolic drugs and in-hospital mortality in ' 'older patients with type 2 diabetes mellitus hospitalized for COVID-19. Preadmission ' 'treatment with dipeptidyl peptidase-4 inhibitors and angiotensin receptor blockers may reduce ' 'in-hospital mortality; other antidiabetic drugs, angiotensin-converting enzyme inhibitors and ' 'statins seem to have a neutral effect; and acetylsalicylic acid may be associated with excess ' 'mortality.</jats:p>', 'DOI': '10.21203/', 'type': 'posted-content', 'created': { 'date-parts': [[2020, 12, 28]], 'date-time': '2020-12-28T21:58:47Z', 'timestamp': 1609192727000}, 'source': 'Crossref', 'is-referenced-by-count': 1, 'title': 'Association between prior cardiometabolic therapy and in-hospital mortality in very old patients ' 'with type 2 diabetes mellitus hospitalized due to COVID-19. A nationwide observational study in ' 'Spain', 'prefix': '10.21203', 'author': [ { 'given': 'Jose Manuel', 'family': 'Ramos-Rincón', 'sequence': 'first', 'affiliation': [ { 'name': 'Miguel Hernandez University of Elche: Universidad Miguel ' 'Hernandez de Elche'}]}, { 'ORCID': '', 'authenticated-orcid': False, 'given': 'Luis M', 'family': 'Pérez-Belmonte', 'sequence': 'additional', 'affiliation': [ { 'name': 'Hospital Regional Universitario de Málaga: Hospital Regional ' 'Universitario de Malaga'}]}, { 'given': 'Francisco Javier', 'family': 'Carrasco-Sánchez', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Juan Ramón Jiménez: Hospital Juan Ramon Jimenez'}]}, { 'given': 'Sergio', 'family': 'Jansen-Chaparro', 'sequence': 'additional', 'affiliation': [ { 'name': 'Hospital Regional Universitario de Málaga: Hospital Regional ' 'Universitario de Malaga'}]}, { 'given': 'Mercedes', 'family': 'De-Sousa-Baena', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Juan Ramón Jiménez: Hospital Juan Ramon Jimenez'}]}, { 'given': 'José', 'family': 'Bueno-Fonseca', 'sequence': 'additional', 'affiliation': [ { 'name': 'Hospital Regional Universitario de Málaga: Hospital Regional ' 'Universitario de Malaga'}]}, { 'given': 'Maria', 'family': 'Pérez-Aguilar', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Juan Ramón Jiménez: Hospital Juan Ramon Jimenez'}]}, { 'given': 'Coral Arévalo', 'family': 'Cañas', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital 12 de Octubre Servicio de Medicina Interna'}]}, { 'given': 'Marta Bacete', 'family': 'Cebrian', 'sequence': 'additional', 'affiliation': [ { 'name': 'Hospital General Universitario Gregorio Marañón: Hospital ' 'General Universitario Gregorio Maranon'}]}, { 'given': 'Manuel', 'family': 'Méndez-Bailón', 'sequence': 'additional', 'affiliation': [ { 'name': 'San Carlos University Hospital Internal Medicine III Service: ' 'Hospital Clinico Universitario San Carlos Servicio de Medicina ' 'Interna III'}]}, { 'given': 'Isabel Fiteni', 'family': 'Mera', 'sequence': 'additional', 'affiliation': [{'name': 'Royo Villanova Hospital: Hospital Royo Villanova'}]}, { 'given': 'Andrés González', 'family': 'García', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Ramon y Cajal: Hospital Universitario Ramon y Cajal'}]}, { 'given': 'Francisco Navarro', 'family': 'Romero', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Costa del Sol'}]}, { 'given': 'Carlota Tuñón de', 'family': 'Almeida', 'sequence': 'additional', 'affiliation': [{'name': ': Complejo Asistencial de Zamora'}]}, { 'given': 'Gemma Muñiz', 'family': 'Nicolás', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Virgen de la Salud'}]}, { 'given': 'Amara González', 'family': 'Noya', 'sequence': 'additional', 'affiliation': [ { 'name': 'Complejo Hospitalario de Orense: Complexo Hospitalario de ' 'Ourense'}]}, { 'given': 'Almudena Hernández', 'family': 'Milian', 'sequence': 'additional', 'affiliation': [ { 'name': 'Hospital Universitario Son Espases: Hospital Universitari Son ' 'Espases'}]}, { 'given': 'Gema María García', 'family': 'García', 'sequence': 'additional', 'affiliation': [{'name': 'Complejo Hospitalario Universitario de Badajoz'}]}, { 'given': 'José Nicolás Alcalá', 'family': 'Pedrajas', 'sequence': 'additional', 'affiliation': [{'name': 'VS Hospital'}]}, { 'given': 'Virginia Herrero', 'family': 'García', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Doctor Jose Molina Orosa'}]}, { 'given': 'Luis', 'family': 'Corral-Gudino', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Universitario Rio Hortega'}]}, { 'given': 'Pere Comas', 'family': 'Casanova', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital de Blanes'}]}, { 'given': 'Héctor Meijide', 'family': 'Míguez', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital QuironSalud A Coruña'}]}, { 'given': 'José Manuel', 'family': 'Casas-Rojo', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Universitario Infanta Cristina'}]}, { 'given': 'Ricardo', 'family': 'Gómez-Huelgas', 'sequence': 'additional', 'affiliation': [ { 'name': 'Regional University Hospital of Malaga: Hospital Regional ' 'Universitario de Malaga'}]}], 'member': '8761', 'container-title': [], 'original-title': [], 'link': [ { 'URL': '', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': '', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 3, 17]], 'date-time': '2021-03-17T17:11:49Z', 'timestamp': 1616001109000}, 'score': 1, 'resource': {'primary': {'URL': ''}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 12, 28]]}, 'references-count': 0, 'URL': '', 'relation': {}, 'published': {'date-parts': [[2020, 12, 28]]}, 'subtype': 'preprint'}
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop